VeraMorph Inc.
Biotechnology company · Mansfield, Massachusetts, United States
VeraMorph Inc. is a biotechnology company headquartered in Mansfield, Massachusetts, United States. Its earliest recorded incorporation is in 2022. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $399,985 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $40,000 sold in a notice filed in 2023.
VeraMorph at a glance
What does VeraMorph do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $399,985 in total (2025). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $40,000 sold (2023).
Frequently asked questions about VeraMorph
Where is VeraMorph headquartered?
VeraMorph Inc. is headquartered in Mansfield, Massachusetts, United States.
What does VeraMorph do?
VeraMorph Inc. is a biotechnology company.
When was VeraMorph founded?
The earliest incorporation on record for VeraMorph Inc. is in 2022, according to public company registers.
Similar companies
- Transplant Genomics Inc.Mansfield, Massachusetts, United States
- Phagepro, Inc.Mansfield, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences